missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Human ADAM19 Antibody, R&D Systems™

Sheep Polyclonal Antibody
Brand: R&D Systems AF5050-SP
This item is not returnable.
View return policy
Description
ADAM19 Polyclonal specifically detects ADAM19 in Human samples. It is validated for Western Blot, Immunoprecipitation.
Specifications
| ADAM19 | |
| Polyclonal | |
| Unconjugated | |
| Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS. with No Preservative | |
| a disintegrin and metalloproteinase domain 19 (meltrin beta), ADAM 19, ADAM metallopeptidase domain 19, disintegrin and metalloproteinase domain-containing protein 19, EC 3.4.24, EC 3.4.24.-, MADDAM, Meltrin beta, Meltrin-beta, Metalloprotease and disintegrin dendritic antigen marker, MLTNBmeltrin beta | |
| Sheep | |
| Affinity Purified | |
| RUO | |
| 8728 | |
| Reconstitute at 0.2 mg/mL in sterile PBS. | |
| Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution. |
| Western Blot, Immunoprecipitation | |
| LYOPH | |
| Western Blot 0.1 ug/mL, Immunoprecipitation 25 ug/mL | |
| Q9H013 | |
| ADAM19 | |
| Chinese hamster ovary cell line CHO-derived recombinant human ADAM19 Arg26-Gln501 (Ser32 del) (Lys33Arg) Accession # Q9H013 | |
| 25 μg | |
| Primary | |
| Detects human ADAM19 in direct ELISAs and Western blots. In direct ELISAs and Western blots, approximately 25% cross-reactivity with recombinant mouse ADAM19 is observed, and less than 5% cross-reactivity with recombinant human (rh) ADAM8, rhADAM12, and rhADAM33 is observed. | |
| Human | |
| IgG |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
For Research Use Only
Spot an opportunity for improvement?Share a Content Correction